Daejeon, South Korea

Chang Hoon Lee

This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, Lg Chem, Ltd, Twinny Co., Ltd.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chang Hoon Lee. Retrieved from https://idiyas.com/inventor/chang-hoon-lee-0fty4uue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chang Hoon Lee: Innovator in Robotics and Pharmaceuticals

Introduction

Chang Hoon Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of robotics and pharmaceuticals, holding a total of 5 patents. His innovative work focuses on enhancing autonomous driving technologies and developing pharmaceutical compositions for serious health conditions.

Latest Patents

One of his latest patents is a multi-traffic control method for a plurality of robots performing autonomous driving. This invention discloses a method for controlling a server that manages the movement schedules of multiple robots. The control method includes receiving occupancy requests for nodes that match scheduled moving routes from the robots. It sets actually occupied and provisionally occupied nodes based on these requests, ensuring that the nodes do not overlap among the robots.

Another significant patent involves pyrazolopyrimidine derivatives, which are used in pharmaceutical compositions for preventing or treating cancer, autoimmune diseases, and brain diseases. This invention highlights a preparation method for these derivatives, which exhibit excellent Bruton's tyrosine kinase inhibition activity, making them effective for treating various serious health conditions.

Career Highlights

Chang Hoon Lee has worked with notable organizations such as the Korea Research Institute of Chemical Technology and LG Chem, Ltd. His experience in these institutions has contributed to his expertise in both chemical technology and pharmaceutical development.

Collaborations

He has collaborated with esteemed colleagues, including Sung Yun Cho and Jong Yeon Hwang, further enhancing the impact of his inventions through teamwork and shared knowledge.

Conclusion

Chang Hoon Lee's innovative contributions to robotics and pharmaceuticals demonstrate his commitment to advancing technology and improving health outcomes. His work continues to influence these fields significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…